313 related articles for article (PubMed ID: 16752394)
1. Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40.
Kumar-Singh S; Theuns J; Van Broeck B; Pirici D; Vennekens K; Corsmit E; Cruts M; Dermaut B; Wang R; Van Broeckhoven C
Hum Mutat; 2006 Jul; 27(7):686-95. PubMed ID: 16752394
[TBL] [Abstract][Full Text] [Related]
2. Evidence that Abeta42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype.
De Jonghe C; Cras P; Vanderstichele H; Cruts M; Vanderhoeven I; Smouts I; Vanmechelen E; Martin JJ; Hendriks L; Van Broeckhoven C
Neurobiol Dis; 1999 Aug; 6(4):280-7. PubMed ID: 10448055
[TBL] [Abstract][Full Text] [Related]
3. A novel presenilin-1 mutation (Leu85Pro) in early-onset Alzheimer disease with spastic paraparesis.
Ataka S; Tomiyama T; Takuma H; Yamashita T; Shimada H; Tsutada T; Kawabata K; Mori H; Miki T
Arch Neurol; 2004 Nov; 61(11):1773-6. PubMed ID: 15534188
[TBL] [Abstract][Full Text] [Related]
4. Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in Abeta 42/40 ratios.
Walker ES; Martinez M; Brunkan AL; Goate A
J Neurochem; 2005 Jan; 92(2):294-301. PubMed ID: 15663477
[TBL] [Abstract][Full Text] [Related]
5. Mean age of onset in familial Alzheimer's disease is determined by amyloid beta 42.
Duering M; Grimm MO; Grimm HS; Schröder J; Hartmann T
Neurobiol Aging; 2005 Jun; 26(6):785-8. PubMed ID: 15718035
[TBL] [Abstract][Full Text] [Related]
6. Decreased Abeta secretion by cells expressing familial Alzheimer's disease-linked mutant presenilin 1.
Shimojo M; Sahara N; Murayama M; Ichinose H; Takashima A
Neurosci Res; 2007 Mar; 57(3):446-53. PubMed ID: 17210196
[TBL] [Abstract][Full Text] [Related]
7. Mutations in presenilin 1, presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer's disease in Poland.
Zekanowski C; Styczyńska M; Pepłońska B; Gabryelewicz T; Religa D; Ilkowski J; Kijanowska-Haładyna B; Kotapka-Minc S; Mikkelsen S; Pfeffer A; Barczak A; Łuczywek E; Wasiak B; Chodakowska-Zebrowska M; Gustaw K; Łaczkowski J; Sobów T; Kuźnicki J; Barcikowska M
Exp Neurol; 2003 Dec; 184(2):991-6. PubMed ID: 14769392
[TBL] [Abstract][Full Text] [Related]
8. Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update.
Raux G; Guyant-Maréchal L; Martin C; Bou J; Penet C; Brice A; Hannequin D; Frebourg T; Campion D
J Med Genet; 2005 Oct; 42(10):793-5. PubMed ID: 16033913
[TBL] [Abstract][Full Text] [Related]
9. A novel mutation in the PSEN2 gene (T430M) associated with variable expression in a family with early-onset Alzheimer disease.
Ezquerra M; Lleó A; Castellví M; Queralt R; Santacruz P; Pastor P; Molinuevo JL; Blesa R; Oliva R
Arch Neurol; 2003 Aug; 60(8):1149-51. PubMed ID: 12925374
[TBL] [Abstract][Full Text] [Related]
10. A novel presenilin-1 mutation: increased beta-amyloid and neurofibrillary changes.
Gómez-Isla T; Wasco W; Pettingell WP; Gurubhagavatula S; Schmidt SD; Jondro PD; McNamara M; Rodes LA; DiBlasi T; Growdon WB; Seubert P; Schenk D; Growdon JH; Hyman BT; Tanzi RE
Ann Neurol; 1997 Jun; 41(6):809-13. PubMed ID: 9189043
[TBL] [Abstract][Full Text] [Related]
11. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635
[TBL] [Abstract][Full Text] [Related]
12. Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life.
Snider BJ; Norton J; Coats MA; Chakraverty S; Hou CE; Jervis R; Lendon CL; Goate AM; McKeel DW; Morris JC
Arch Neurol; 2005 Dec; 62(12):1821-30. PubMed ID: 16344340
[TBL] [Abstract][Full Text] [Related]
13. Variations in the neuropathology of familial Alzheimer's disease.
Shepherd C; McCann H; Halliday GM
Acta Neuropathol; 2009 Jul; 118(1):37-52. PubMed ID: 19306098
[TBL] [Abstract][Full Text] [Related]
14. Modeling clinically heterogeneous presenilin mutations with transgenic Drosophila.
Seidner GA; Ye Y; Faraday MM; Alvord WG; Fortini ME
Curr Biol; 2006 May; 16(10):1026-33. PubMed ID: 16713961
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal observation on CSF Abeta42 levels in young to middle-aged amyloid precursor protein/presenilin-1 doubly transgenic mice.
Liu L; Herukka SK; Minkeviciene R; van Groen T; Tanila H
Neurobiol Dis; 2004 Dec; 17(3):516-23. PubMed ID: 15571987
[TBL] [Abstract][Full Text] [Related]
16. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.
Flood DG; Lin YG; Lang DM; Trusko SP; Hirsch JD; Savage MJ; Scott RW; Howland DS
Neurobiol Aging; 2009 Jul; 30(7):1078-90. PubMed ID: 18053619
[TBL] [Abstract][Full Text] [Related]
17. [Alzheimer's disease due to presenilin mutations].
Tabira T
Nihon Rinsho; 2004 Jan; 62 Suppl():90-4. PubMed ID: 15011327
[No Abstract] [Full Text] [Related]
18. Increased Abeta42(43) from cell lines expressing presenilin 1 mutations.
Mehta ND; Refolo LM; Eckman C; Sanders S; Yager D; Perez-Tur J; Younkin S; Duff K; Hardy J; Hutton M
Ann Neurol; 1998 Feb; 43(2):256-8. PubMed ID: 9485068
[TBL] [Abstract][Full Text] [Related]
19. Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype.
Piccini A; Zanusso G; Borghi R; Noviello C; Monaco S; Russo R; Damonte G; Armirotti A; Gelati M; Giordano R; Zambenedetti P; Russo C; Ghetti B; Tabaton M
Arch Neurol; 2007 May; 64(5):738-45. PubMed ID: 17502474
[TBL] [Abstract][Full Text] [Related]
20. Genetic study of Sardinian patients with Alzheimer's disease.
Piscopo P; Manfredi A; Malvezzi-Campeggi L; Crestini A; Spadoni O; Cherchi R; Deiana E; Piras MR; Confaloni A
Neurosci Lett; 2006 May; 398(1-2):124-8. PubMed ID: 16423463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
